Evidence map›Paper›PMID 41745294›Full record

ReviewJournal of fungi (Basel, Switzerland)2026

Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents.

Guillermo Quindós, Iker De-la-Pinta, Cristina Marcos-Arias, Nerea Jauregizar, Elena Sevillano, Lucila Madariaga, Elena Eraso

Abstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Salvianolic acid B synergizes with azoles againstFrontiers in cellular and infection microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guillermo QuindósDepartment of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48080 Bilbao, Spain.ORCID 0000-0003-0438-2248
Iker De-la-PintaDepartment of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48080 Bilbao, Spain.ORCID 0000-0002-7109-7570
Cristina Marcos-AriasDepartment of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48080 Bilbao, Spain.ORCID 0000-0002-0924-3696
Nerea JauregizarInstituto de Investigación Sanitaria Biobizkaia, 48903 Barakaldo, Spain.ORCID 0000-0002-8738-0901
Elena SevillanoDepartment of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48080 Bilbao, Spain.ORCID 0000-0002-3472-984X
Lucila MadariagaDepartment of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48080 Bilbao, Spain.
Elena ErasoDepartment of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48080 Bilbao, Spain.ORCID 0000-0002-9043-9265

Funding

Consejería de Educación, Universidades e Investigación of the Gobierno Vasco-Eusko Jaularitza GIC21/24 IT1607-22
6 · The paper itself

Abstract

Vulvovaginal candidiasis (VVC) represents a widespread gynaecological challenge, affecting approximately 75% of women at some point during their reproductive years, with a significant subset progressing to recurrent forms (RVVC). Classical azoles and polyenes remain the cornerstone of therapy. However, their clinical utility is undermined by the rise of azole-resistant non-

Indexed as

antifungal treatmentazolesclotrimazolefluconazoleibrexafungerpmiconazolenystatinoteseconazolevulvovaginal candidiasis

Identifiers

PMID41745294
PMCPMC12941849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.